In 2016 Yan He Xu was appointed CEO of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329). First, this article will compare CEO compensation with compensation at similar sized ...
GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more ...
Visit a quote page and your recently viewed tickers will be displayed here.
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) shares have had a really impressive month, gaining 33%, after some slippage. But shareholders may not all be feeling jubilant, since the share ...
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines, and healthcare food products. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results